ADSS1

UniProt ID: Q8N142
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

Muscle (basic/M-type) isozyme of adenylosuccinate synthetase (AMPSase 1; synonym ADSSL1; EC 6.3.4.4), a cytosolic homodimeric enzyme predominantly expressed in skeletal muscle and heart. It catalyzes the first, committed step of the IMP-to-AMP branch of purine metabolism, the Mg2+-dependent, GTP-driven condensation of IMP with L-aspartate to form N6-(1,2-dicarboxyethyl)-AMP (adenylosuccinate/S-AMP), GDP and phosphate; adenylosuccinate lyase (ADSL) then cleaves S-AMP to AMP and fumarate. Together with ADSL, ADSS1 also runs the AMP-regenerating limb of the muscle purine nucleotide cycle, which interconverts IMP and AMP and contributes to muscle energetics (glycolysis) and ammoniagenesis. The paralog ADSS2 is the liver/ubiquitous (acidic) isozyme. Biallelic loss-of-function variants in ADSS1 cause adenylosuccinate synthetase 1 (ADSSL1)-related distal myopathy (MPD5), an autosomal recessive adolescent/adult-onset distal myopathy.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004019 adenylosuccinate synthase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred adenylosuccinate synthase activity, the defining molecular function of ADSS1 and the entire adenylosuccinate synthetase family. This is directly confirmed experimentally for the human protein.
Reason: This is the core, well-supported molecular function. The IBA is grounded in a broad set of orthologs (E. coli purA, yeast, mouse muscle/non-muscle isozymes) and is confirmed for the human enzyme by direct assay (PMID:15786719) and by a mutation study (PMID:26506222).
Supporting Evidence:
PMID:15786719
Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation.
GO:0005737 cytoplasm
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred cytoplasmic localization, consistent with the experimentally observed cytoplasmic localization of the human protein.
Reason: Adenylosuccinate synthetase is a soluble cytosolic enzyme across the family; the human protein was directly observed in the cytoplasm when overexpressed (PMID:15786719). Cytosol (GO:0005829) is the more precise term captured elsewhere.
Supporting Evidence:
PMID:15786719
Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
GO:0044208 'de novo' AMP biosynthetic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred role in de novo AMP biosynthesis. ADSS1 catalyzes step 1 of 2 of the conversion of IMP to AMP, the first committed step of the de novo AMP branch of purine metabolism.
Reason: This is a core biological process for the gene, matching the UniProt-annotated pathway (AMP biosynthesis via the de novo pathway, AMP from IMP, step 1 of 2). Well supported by orthology and by the enzyme's characterized reaction.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP
GO:0046040 IMP metabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred involvement in IMP metabolism. IMP is the direct substrate of adenylosuccinate synthase, consumed in the first committed step of AMP synthesis.
Reason: Accurate; ADSS1 consumes IMP (with GTP and aspartate) and, as part of the purine nucleotide cycle, contributes to IMP/AMP interconversion. Broader than the specific catalytic function but a correct process annotation.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
GO:0000166 nucleotide binding
IEA
GO_REF:0000002
ACCEPT
Summary: InterPro-based inference of nucleotide binding. ADSS1 binds GTP (and its product GDP) and IMP as substrates; nucleotide binding is a general parent of these specific activities.
Reason: Correct but general. The enzyme has a P-loop NTPase fold and documented GTP/IMP binding sites (UniProt BINDING features). More specific GTP binding (GO:0005525) is also annotated. Retained as an accurate, if broad, molecular-function annotation.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Nucleotide-binding
GO:0000287 magnesium ion binding
IEA
GO_REF:0000104
ACCEPT
Summary: Rule-based inference of magnesium ion binding. Adenylosuccinate synthase is a Mg2+-dependent enzyme that binds one Mg2+ ion per subunit, coordinating the GTP/phosphoryl-transfer chemistry.
Reason: Supported by UniProt cofactor and binding-site annotations (Mg2+ bound at residues 43 and 70), consistent with the conserved catalytic mechanism of the family.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Binds 1 Mg(2+) ion per subunit.
GO:0004019 adenylosuccinate synthase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (ARBA/UniRule/InterPro/RHEA/EC) inference of the core adenylosuccinate synthase activity, duplicating the experimentally and phylogenetically supported molecular function.
Reason: Correct core molecular function (EC 6.3.4.4; RHEA 15753), consistent with the IDA, IMP, and IBA annotations for the same term.
Supporting Evidence:
PMID:15786719
Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation.
GO:0005525 GTP binding
IEA
GO_REF:0000120
ACCEPT
Summary: Automated inference of GTP binding. GTP is a required co-substrate of the adenylosuccinate synthase reaction, providing the energy for the ligation and being converted to GDP + phosphate.
Reason: Well supported; UniProt documents multiple GTP-binding regions (residues 42-48, 70-72, 337, 363-365, 445-448) and the reaction consumes GTP. Also independently annotated NAS from PMID:15786719.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
N(6)-(1,2-dicarboxyethyl)-AMP + GDP
GO:0005737 cytoplasm
IEA
GO_REF:0000120
ACCEPT
Summary: Automated inference of cytoplasmic localization, matching the experimental cytoplasmic localization and the cytosol annotation.
Reason: Consistent with UniProt subcellular location (Cytoplasm) and the direct experimental observation in PMID:15786719.
Supporting Evidence:
PMID:15786719
Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
GO:0006164 purine nucleotide biosynthetic process
IEA
GO_REF:0000002
ACCEPT
Summary: InterPro-based inference of involvement in purine nucleotide biosynthesis. ADSS1 acts in the IMP-to-AMP branch, producing the purine nucleotide AMP.
Reason: Correct but general parent of the more specific AMP biosynthesis terms; retained as an accurate process annotation.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
GO:0006167 AMP biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: Automated inference of involvement in AMP biosynthesis, the direct downstream product process of the adenylosuccinate synthase reaction (via ADSL cleavage of S-AMP to AMP). Also independently supported by IDA (PMID:15786719).
Reason: Core biological process; the enzyme catalyzes the committed step producing the AMP precursor adenylosuccinate.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
GO:0044208 'de novo' AMP biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (UniRule/UniPathway) inference of the de novo AMP biosynthetic process, matching the IBA annotation and the UniProt pathway assignment.
Reason: Correct and specific core process (de novo AMP-from-IMP pathway, step 1 of 2).
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
AMP biosynthesis via de novo pathway
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520, the paralog ADSS2). "Protein binding" is uninformative as a molecular function.
Reason: The bare GO:0005515 term conveys no specific function. The recorded partner is the paralog ADSS2, consistent with the UniProt-documented ADSS1-ADSS2 interaction, but this is a large-scale interactome dataset that does not establish a discrete functional MF for ADSS1. Per curation policy, retained (not removed) but flagged as over-annotation; the informative function is captured by GO:0004019.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Q8N142; P30520: ADSS2; NbExp=4
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520, the paralog ADSS2). Uninformative bare protein-binding term.
Reason: As above, a high-throughput interactome mapping to the paralog ADSS2. Retained per policy but flagged as over-annotation; adds no specific molecular function beyond the adenylosuccinate synthase activity.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Q8N142; P30520: ADSS2; NbExp=4
GO:0005515 protein binding
IPI
PMID:40205054
Multimodal cell maps as a foundation for structural and func...
MARK AS OVER ANNOTATED
Summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520, the paralog ADSS2). Uninformative bare protein-binding term.
Reason: As above, a multimodal cell-map / interactome dataset mapping to ADSS2. Retained per policy but flagged as over-annotation.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Q8N142; P30520: ADSS2; NbExp=4
GO:0044209 AMP salvage
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Ensembl-orthology inference of involvement in AMP salvage. ADSS1 in muscle operates the AMP-regenerating limb of the purine nucleotide cycle (IMP to AMP), which recycles the purine nucleotide pool.
Reason: The primary and precise characterization of ADSS1 is de novo AMP biosynthesis (AMP from IMP, step 1 of 2). AMP salvage (reuse of preformed adenine/adenosine) is not the enzyme's committed-step chemistry; the overlap is via the purine nucleotide cycle that regenerates AMP from IMP. Kept as it is not strictly wrong, but flagged as a less precise, orthology-transferred process; GO:0044208 is the accurate term.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
which interconverts IMP and AMP to regulate the nucleotide levels
GO:0004019 adenylosuccinate synthase activity
IMP
PMID:26506222
ADSSL1 mutation relevant to autosomal recessive adolescent o...
ACCEPT
Summary: Adenylosuccinate synthase activity inferred from mutant phenotype; disease variants in ADSSL1 reduce catalytic activity, confirming that the wild-type protein provides this function.
Reason: Direct genetic/functional evidence. Both MPD5 mutations (p.D304N and p.I350fs) decreased enzymatic activity, and the D261N variant characterized in UniProt shows decreased adenylosuccinate synthase activity, tying the human gene product's core catalytic function to disease.
Supporting Evidence:
PMID:26506222
Both the D304N and I350fs mutations in ADSSL1 led to decreased enzymatic activity.
GO:0005829 cytosol
TAS
Reactome:R-HSA-111524
ACCEPT
Summary: Cytosolic localization asserted by Reactome for the adenylosuccinate synthase reaction, consistent with the soluble cytosolic nature of the enzyme.
Reason: Cytosol is the precise cellular component for this soluble enzyme, agreeing with the experimental cytoplasm localization (PMID:15786719) and UniProt subcellular location. This is the preferred specific location term.
Supporting Evidence:
Reactome:R-HSA-111524
Two isoforms of adenylosuccinate synthetase, ADSS and ADSSL1, catalyze the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP, and orthophosphate
GO:0002376 immune system process
NAS
PMID:15786719
Molecular cloning and characterization of a novel muscle ade...
KEEP AS NON CORE
Summary: Non-traceable author statement based on the observation that AdSSL1 is expressed in hematopoietic/leukemia cell lines in a stimulation-dependent manner. This is an expression correlation, not an established immune function.
Reason: ADSS1 is fundamentally a purine-metabolism enzyme predominantly expressed in muscle; the immune-system link rests only on expression in leukemia cells after stimulation, with no demonstrated mechanistic immune role. Kept as a non-core, weakly-supported process rather than a core function.
Supporting Evidence:
PMID:15786719
After stimulation, leukemia cells express AdSSL1 in a time-dependent manner
GO:0004019 adenylosuccinate synthase activity
IDA
PMID:15786719
Molecular cloning and characterization of a novel muscle ade...
ACCEPT
Summary: Direct assay of recombinant human AdSSL1 demonstrating adenylosuccinate synthase activity (adenylosuccinate formation). This is the primary experimental evidence for the core molecular function.
Reason: Strong direct experimental support for the defining catalytic activity of the gene product.
Supporting Evidence:
PMID:15786719
Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation.
GO:0005525 GTP binding
NAS
PMID:15786719
Molecular cloning and characterization of a novel muscle ade...
ACCEPT
Summary: Author statement of GTP binding, reflecting the conserved GTP-dependent mechanism of adenylosuccinate synthetase; GTP is a co-substrate of the reaction.
Reason: Consistent with the well-characterized GTP-dependent catalytic mechanism and the multiple GTP-binding regions annotated in UniProt; also independently supported by IEA.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
N(6)-(1,2-dicarboxyethyl)-AMP + GDP
GO:0005737 cytoplasm
IDA
PMID:15786719
Molecular cloning and characterization of a novel muscle ade...
ACCEPT
Summary: Direct experimental observation that overexpressed AdSSL1 localizes to the cytoplasm in COS-7 cells.
Reason: Direct localization evidence for the human protein; cytosol (GO:0005829) is the more granular equivalent captured from Reactome.
Supporting Evidence:
PMID:15786719
Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
GO:0006167 AMP biosynthetic process
IDA
PMID:15786719
Molecular cloning and characterization of a novel muscle ade...
ACCEPT
Summary: Direct evidence linking ADSS1 to AMP biosynthesis via its characterized adenylosuccinate-forming activity, the committed step in AMP synthesis.
Reason: Core biological process, directly supported by the enzyme assay and the description of AdSSL1 as catalyzing the first committed step in AMP synthesis.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
GO:0042301 phosphate ion binding
NAS
PMID:15786719
Molecular cloning and characterization of a novel muscle ade...
MARK AS OVER ANNOTATED
Summary: Author statement of phosphate ion binding. Phosphate is a reaction product and the enzyme binds the phosphate groups of its GTP/GDP and IMP ligands, but a standalone phosphate-ion-binding molecular function is not informative for this enzyme.
Reason: The enzyme's phosphate handling is part of GTP binding and the ligase catalytic mechanism (phosphate is released as a product). A discrete phosphate-ion-binding MF annotation adds little and risks over-representing an incidental feature; the informative functions are GO:0004019 and GO:0005525. Kept (not wrong) but flagged.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
N(6)-(1,2-dicarboxyethyl)-AMP + GDP + phosphate

Core Functions

Catalyzes the first committed step of AMP biosynthesis from IMP - the Mg2+-dependent, GTP-driven condensation of IMP with L-aspartate to yield adenylosuccinate (N6-(1,2-dicarboxyethyl)-AMP), GDP and phosphate (EC 6.3.4.4) - as the muscle isozyme of adenylosuccinate synthetase.

Supporting Evidence:
  • PMID:15786719
    Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation.
  • PMID:26506222
    Both the D304N and I350fs mutations in ADSSL1 led to decreased enzymatic activity.

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Electronic Gene Ontology annotations created by transferring manual GO annotations between related proteins based on shared sequence features
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Molecular cloning and characterization of a novel muscle adenylosuccinate synthetase, AdSSL1, from human bone marrow stromal cells.
  • Human AdSSL1 is the muscle isozyme of adenylosuccinate synthetase that catalyzes the first committed step in AMP synthesis; recombinant protein has typical adenylosuccinate synthase activity and the protein localizes to the cytoplasm.
    "Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation."
ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy.
  • Biallelic ADSSL1 mutations cause autosomal recessive adolescent-onset distal myopathy (MPD5); the mutations decrease adenylosuccinate synthase enzymatic activity.
    "Both the D304N and I350fs mutations in ADSSL1 led to decreased enzymatic activity."
Architecture of the human interactome defines protein communities and disease networks.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Multimodal cell maps as a foundation for structural and functional genomics.
Reactome:R-HSA-111524
IMP + L-Aspartate + GTP => Adenylosuccinate + GDP + Pi [ADSS]
  • Adenylosuccinate synthetase isoforms (including ADSSL1) catalyze the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP and orthophosphate in the cytosol.
    "Two isoforms of adenylosuccinate synthetase, ADSS and ADSSL1, catalyze the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP, and orthophosphate"
file:human/ADSS1/ADSS1-uniprot.txt
UniProt entry Q8N142 (PURA1_HUMAN, ADSS1) - adenylosuccinate synthetase isozyme 1
  • ADSS1 catalyzes the Mg2+-dependent, GTP-dependent reaction of IMP with L-aspartate to form adenylosuccinate, GDP and phosphate, the first committed step (step 1 of 2) of the de novo AMP-from-IMP pathway; it is a cytoplasmic homodimer that interacts with the paralog ADSS2.
    "N(6)-(1,2-dicarboxyethyl)-AMP + GDP"

Suggested Questions for Experts

Q: Does ADSS1 have non-catalytic or muscle-specific regulatory roles beyond the purine nucleotide cycle that explain the tissue-restricted, distal-predominant myopathy phenotype, given the ubiquitously expressed paralog ADSS2?

Q: Is the observed expression of AdSSL1 in stimulated leukemia/hematopoietic cells associated with any genuine immune function, or purely a metabolic response?

Suggested Experiments

Experiment: Steady-state kinetic characterization of purified recombinant human ADSS1 (Km for IMP, L-aspartate, GTP; Mg2+ dependence) compared with ADSS2, to quantify the muscle isozyme's catalytic properties.

Hypothesis: The muscle isozyme ADSS1 has kinetic properties distinct from ADSS2 that suit the high purine-nucleotide-cycle flux of skeletal muscle.

Experiment: Muscle-specific Adss1 knockout or knock-in of the MPD5 D304N variant in mouse to test whether purine nucleotide cycle disruption drives the distal myopathy phenotype.

Hypothesis: Loss of ADSS1 catalytic activity impairs the muscle purine nucleotide cycle, causing the distal myopathy seen in MPD5 patients.

📚 Additional Documentation

Notes

(ADSS1-notes.md)

ADSS1 (Q8N142 / PURA1_HUMAN) review notes

Deep research: falcon provider is out of credits (HTTP 402); no -deep-research-falcon.md
was generated. Review grounded in the cached UniProt record, the seeded GOA, and cached
publications/PMID_*.md. No content was fabricated as deep research.

Identity

  • ADSS1 = adenylosuccinate synthetase isozyme 1, the muscle (basic / M-type) isozyme
    (synonym ADSSL1). Paralog ADSS2 (P30520) is the liver/ubiquitous ("acidic") isozyme.
  • EC 6.3.4.4; RHEA:15753. HGNC:20093; chromosome 14. UniProt PE 1 (protein-level evidence).
  • 457 aa homodimer; belongs to the adenylosuccinate synthetase family (HAMAP MF_03126);
    P-loop NTPase fold with three Gene3D domains (CDD cd03108 AdSS).

Reaction / function

  • Catalyses the first committed step of AMP synthesis from IMP:
    IMP + L-aspartate + GTP = N6-(1,2-dicarboxyethyl)-AMP (adenylosuccinate / S-AMP)
  • GDP + phosphate + 2 H+ [UniProt CATALYTIC ACTIVITY; RHEA:15753].
    Mg2+-dependent (binds 1 Mg2+ per subunit) [UniProt COFACTOR].
  • Adenylosuccinate lyase (ADSL) then cleaves S-AMP -> AMP + fumarate (second step).
  • PATHWAY: "Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP:
    step 1/2" [UniProt PATHWAY; UniPathway UPA00075/UER00335].
  • Component of the purine nucleotide cycle (PNC) which interconverts IMP and AMP to
    regulate nucleotide levels; contributes to glycolysis and ammoniagenesis in muscle
    [UniProt FUNCTION, ECO:0000269|PubMed:26506222].

Key experimental evidence

  • PMID:15786719 (Sun et al. 2005) — cloned human AdSSL1 from bone marrow stromal cells;
    "catalyzes the first committed step in AMP synthesis"; recombinant protein "possesses
    typical enzymatic activity to catalyze adenylosuccinate formation" (IDA GO:0004019);
    "Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm" (IDA cytoplasm);
    "predominantly expressed in skeletal muscle and cardiac tissue". Abstract-only in cache.
    This paper is also the NAS source for GTP binding, phosphate ion binding, and
    "immune system process" (leukemia-cell expression framing).
  • PMID:26506222 (Park et al. 2016, Ann Neurol) — compound-het ADSSL1 mutations
    (p.D304N and p.I350fs) cause autosomal-recessive adolescent-onset distal myopathy (MPD5,
    MIM 617030). "Both the D304N and I350fs mutations in ADSSL1 led to decreased enzymatic
    activity." D261N (=D304N in another numbering) VARIANT: decreased activity/stability.
    IMP GO:0004019 by IMP (mutation -> loss of catalytic activity). Abstract-only in cache.

Cellular location

  • Cytoplasm / cytosol [UniProt SUBCELLULAR LOCATION Cytoplasm; Reactome R-HSA-111524 cytosol TAS].

Interactions (IPI, GO:0005515 protein binding)

  • Three IntAct proteome-scale IPIs (PMID:28514442, 33961781, 40205054) all with
    WITH/FROM = UniProtKB:P30520 (ADSS2). UniProt INTERACTION records the ADSS1–ADSS2
    interaction (NbExp=4). Cached texts are the large interactome papers and do not name
    ADSS1 in the body. Per curation policy, bare protein binding IPIs -> MARK_AS_OVER_ANNOTATED
    (uninformative MF term), not REMOVE.

Curation decisions summary

  • Core MF: GO:0004019 adenylosuccinate synthase activity (IBA/IEA/IMP/IDA) — ACCEPT.
  • GTP binding GO:0005525, Mg2+ binding GO:0000287, nucleotide binding GO:0000166 — molecular
    detail of the catalytic mechanism; ACCEPT (nucleotide binding is a general parent of GTP
    binding — keep, non-core-ish but accurate).
  • BP: 'de novo' AMP biosynthetic process GO:0044208, AMP biosynthetic process GO:0006167,
    purine nucleotide biosynthetic process GO:0006164 — ACCEPT (directly involved).
  • IMP metabolic process GO:0046040 — ACCEPT (IMP is the substrate).
  • AMP salvage GO:0044209 (IEA, Ensembl orthology) — ADSS1 is a de novo AMP biosynthesis
    enzyme; in muscle it runs the PNC AMP-regenerating limb, which is functionally part of
    purine salvage/recycling. Keep but MARK_AS_OVER_ANNOTATED — "salvage" (reuse of preformed
    bases/nucleosides) is not the precise process; the committed IMP->AMP step is de novo.
  • cytoplasm GO:0005737 / cytosol GO:0005829 — ACCEPT.
  • immune system process GO:0002376 (NAS, PMID:15786719) — based on leukemia-cell expression;
    no functional immune role established. KEEP_AS_NON_CORE (weak, expression-based).
  • phosphate ion binding GO:0042301 (NAS) — phosphate is a product, and the enzyme binds
    GTP/GDP phosphates; MARK_AS_OVER_ANNOTATED (not an informative standalone MF).
  • protein binding GO:0005515 x3 — MARK_AS_OVER_ANNOTATED.

📄 View Raw YAML

id: Q8N142
gene_symbol: ADSS1
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: Muscle (basic/M-type) isozyme of adenylosuccinate synthetase (AMPSase 1;
  synonym ADSSL1; EC 6.3.4.4), a cytosolic homodimeric enzyme predominantly expressed
  in skeletal muscle and heart. It catalyzes the first, committed step of the IMP-to-AMP
  branch of purine metabolism, the Mg2+-dependent, GTP-driven condensation of IMP with
  L-aspartate to form N6-(1,2-dicarboxyethyl)-AMP (adenylosuccinate/S-AMP), GDP and phosphate;
  adenylosuccinate lyase (ADSL) then cleaves S-AMP to AMP and fumarate. Together with ADSL,
  ADSS1 also runs the AMP-regenerating limb of the muscle purine nucleotide cycle, which
  interconverts IMP and AMP and contributes to muscle energetics (glycolysis) and
  ammoniagenesis. The paralog ADSS2 is the liver/ubiquitous (acidic) isozyme. Biallelic
  loss-of-function variants in ADSS1 cause adenylosuccinate synthetase 1 (ADSSL1)-related
  distal myopathy (MPD5), an autosomal recessive adolescent/adult-onset distal myopathy.
alternative_products:
- name: '1'
  id: Q8N142-1
- name: '2'
  id: Q8N142-2
  sequence_note: VSP_008421
existing_annotations:
- term:
    id: GO:0004019
    label: adenylosuccinate synthase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: Phylogenetically inferred adenylosuccinate synthase activity, the defining
      molecular function of ADSS1 and the entire adenylosuccinate synthetase family.
      This is directly confirmed experimentally for the human protein.
    action: ACCEPT
    reason: This is the core, well-supported molecular function. The IBA is grounded in a
      broad set of orthologs (E. coli purA, yeast, mouse muscle/non-muscle isozymes) and is
      confirmed for the human enzyme by direct assay (PMID:15786719) and by a mutation study
      (PMID:26506222).
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
        catalyze adenylosuccinate formation.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: Phylogenetically inferred cytoplasmic localization, consistent with the
      experimentally observed cytoplasmic localization of the human protein.
    action: ACCEPT
    reason: Adenylosuccinate synthetase is a soluble cytosolic enzyme across the family;
      the human protein was directly observed in the cytoplasm when overexpressed
      (PMID:15786719). Cytosol (GO:0005829) is the more precise term captured elsewhere.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
- term:
    id: GO:0044208
    label: "'de novo' AMP biosynthetic process"
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: Phylogenetically inferred role in de novo AMP biosynthesis. ADSS1 catalyzes
      step 1 of 2 of the conversion of IMP to AMP, the first committed step of the de novo
      AMP branch of purine metabolism.
    action: ACCEPT
    reason: This is a core biological process for the gene, matching the UniProt-annotated
      pathway (AMP biosynthesis via the de novo pathway, AMP from IMP, step 1 of 2). Well
      supported by orthology and by the enzyme's characterized reaction.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: Purine metabolism; AMP biosynthesis via de novo pathway; AMP
        from IMP
- term:
    id: GO:0046040
    label: IMP metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: Phylogenetically inferred involvement in IMP metabolism. IMP is the direct
      substrate of adenylosuccinate synthase, consumed in the first committed step of
      AMP synthesis.
    action: ACCEPT
    reason: Accurate; ADSS1 consumes IMP (with GTP and aspartate) and, as part of the
      purine nucleotide cycle, contributes to IMP/AMP interconversion. Broader than the
      specific catalytic function but a correct process annotation.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
    id: GO:0000166
    label: nucleotide binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: InterPro-based inference of nucleotide binding. ADSS1 binds GTP (and its
      product GDP) and IMP as substrates; nucleotide binding is a general parent of these
      specific activities.
    action: ACCEPT
    reason: Correct but general. The enzyme has a P-loop NTPase fold and documented GTP/IMP
      binding sites (UniProt BINDING features). More specific GTP binding (GO:0005525) is
      also annotated. Retained as an accurate, if broad, molecular-function annotation.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: Nucleotide-binding
- term:
    id: GO:0000287
    label: magnesium ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000104
  qualifier: enables
  review:
    summary: Rule-based inference of magnesium ion binding. Adenylosuccinate synthase is
      a Mg2+-dependent enzyme that binds one Mg2+ ion per subunit, coordinating the
      GTP/phosphoryl-transfer chemistry.
    action: ACCEPT
    reason: Supported by UniProt cofactor and binding-site annotations (Mg2+ bound at
      residues 43 and 70), consistent with the conserved catalytic mechanism of the family.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: Binds 1 Mg(2+) ion per subunit.
- term:
    id: GO:0004019
    label: adenylosuccinate synthase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Automated (ARBA/UniRule/InterPro/RHEA/EC) inference of the core adenylosuccinate
      synthase activity, duplicating the experimentally and phylogenetically supported
      molecular function.
    action: ACCEPT
    reason: Correct core molecular function (EC 6.3.4.4; RHEA 15753), consistent with the
      IDA, IMP, and IBA annotations for the same term.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
        catalyze adenylosuccinate formation.
- term:
    id: GO:0005525
    label: GTP binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Automated inference of GTP binding. GTP is a required co-substrate of the
      adenylosuccinate synthase reaction, providing the energy for the ligation and being
      converted to GDP + phosphate.
    action: ACCEPT
    reason: Well supported; UniProt documents multiple GTP-binding regions (residues 42-48,
      70-72, 337, 363-365, 445-448) and the reaction consumes GTP. Also independently
      annotated NAS from PMID:15786719.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: Automated inference of cytoplasmic localization, matching the experimental
      cytoplasmic localization and the cytosol annotation.
    action: ACCEPT
    reason: Consistent with UniProt subcellular location (Cytoplasm) and the direct
      experimental observation in PMID:15786719.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
- term:
    id: GO:0006164
    label: purine nucleotide biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: InterPro-based inference of involvement in purine nucleotide biosynthesis.
      ADSS1 acts in the IMP-to-AMP branch, producing the purine nucleotide AMP.
    action: ACCEPT
    reason: Correct but general parent of the more specific AMP biosynthesis terms; retained
      as an accurate process annotation.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
    id: GO:0006167
    label: AMP biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: Automated inference of involvement in AMP biosynthesis, the direct downstream
      product process of the adenylosuccinate synthase reaction (via ADSL cleavage of S-AMP
      to AMP). Also independently supported by IDA (PMID:15786719).
    action: ACCEPT
    reason: Core biological process; the enzyme catalyzes the committed step producing the
      AMP precursor adenylosuccinate.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
    id: GO:0044208
    label: "'de novo' AMP biosynthetic process"
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: Automated (UniRule/UniPathway) inference of the de novo AMP biosynthetic
      process, matching the IBA annotation and the UniProt pathway assignment.
    action: ACCEPT
    reason: Correct and specific core process (de novo AMP-from-IMP pathway, step 1 of 2).
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: AMP biosynthesis via de novo pathway
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520,
      the paralog ADSS2). "Protein binding" is uninformative as a molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: The bare GO:0005515 term conveys no specific function. The recorded partner is
      the paralog ADSS2, consistent with the UniProt-documented ADSS1-ADSS2 interaction, but
      this is a large-scale interactome dataset that does not establish a discrete functional
      MF for ADSS1. Per curation policy, retained (not removed) but flagged as
      over-annotation; the informative function is captured by GO:0004019.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: "Q8N142; P30520: ADSS2; NbExp=4"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520,
      the paralog ADSS2). Uninformative bare protein-binding term.
    action: MARK_AS_OVER_ANNOTATED
    reason: As above, a high-throughput interactome mapping to the paralog ADSS2. Retained
      per policy but flagged as over-annotation; adds no specific molecular function beyond
      the adenylosuccinate synthase activity.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: "Q8N142; P30520: ADSS2; NbExp=4"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:40205054
  qualifier: enables
  review:
    summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520,
      the paralog ADSS2). Uninformative bare protein-binding term.
    action: MARK_AS_OVER_ANNOTATED
    reason: As above, a multimodal cell-map / interactome dataset mapping to ADSS2. Retained
      per policy but flagged as over-annotation.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: "Q8N142; P30520: ADSS2; NbExp=4"
- term:
    id: GO:0044209
    label: AMP salvage
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Ensembl-orthology inference of involvement in AMP salvage. ADSS1 in muscle
      operates the AMP-regenerating limb of the purine nucleotide cycle (IMP to AMP), which
      recycles the purine nucleotide pool.
    action: MARK_AS_OVER_ANNOTATED
    reason: The primary and precise characterization of ADSS1 is de novo AMP biosynthesis
      (AMP from IMP, step 1 of 2). AMP salvage (reuse of preformed adenine/adenosine) is not
      the enzyme's committed-step chemistry; the overlap is via the purine nucleotide cycle
      that regenerates AMP from IMP. Kept as it is not strictly wrong, but flagged as a less
      precise, orthology-transferred process; GO:0044208 is the accurate term.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: which interconverts IMP and AMP to regulate the nucleotide levels
- term:
    id: GO:0004019
    label: adenylosuccinate synthase activity
  evidence_type: IMP
  original_reference_id: PMID:26506222
  qualifier: enables
  review:
    summary: Adenylosuccinate synthase activity inferred from mutant phenotype; disease
      variants in ADSSL1 reduce catalytic activity, confirming that the wild-type protein
      provides this function.
    action: ACCEPT
    reason: Direct genetic/functional evidence. Both MPD5 mutations (p.D304N and p.I350fs)
      decreased enzymatic activity, and the D261N variant characterized in UniProt shows
      decreased adenylosuccinate synthase activity, tying the human gene product's core
      catalytic function to disease.
    supported_by:
    - reference_id: PMID:26506222
      supporting_text: Both the D304N and I350fs mutations in ADSSL1 led to decreased
        enzymatic activity.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-111524
  qualifier: located_in
  review:
    summary: Cytosolic localization asserted by Reactome for the adenylosuccinate synthase
      reaction, consistent with the soluble cytosolic nature of the enzyme.
    action: ACCEPT
    reason: Cytosol is the precise cellular component for this soluble enzyme, agreeing with
      the experimental cytoplasm localization (PMID:15786719) and UniProt subcellular
      location. This is the preferred specific location term.
    supported_by:
    - reference_id: Reactome:R-HSA-111524
      supporting_text: Two isoforms of adenylosuccinate synthetase, ADSS and ADSSL1, catalyze
        the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP, and
        orthophosphate
- term:
    id: GO:0002376
    label: immune system process
  evidence_type: NAS
  original_reference_id: PMID:15786719
  qualifier: involved_in
  review:
    summary: Non-traceable author statement based on the observation that AdSSL1 is
      expressed in hematopoietic/leukemia cell lines in a stimulation-dependent manner.
      This is an expression correlation, not an established immune function.
    action: KEEP_AS_NON_CORE
    reason: ADSS1 is fundamentally a purine-metabolism enzyme predominantly expressed in
      muscle; the immune-system link rests only on expression in leukemia cells after
      stimulation, with no demonstrated mechanistic immune role. Kept as a non-core,
      weakly-supported process rather than a core function.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: After stimulation, leukemia cells express AdSSL1 in a time-dependent
        manner
- term:
    id: GO:0004019
    label: adenylosuccinate synthase activity
  evidence_type: IDA
  original_reference_id: PMID:15786719
  qualifier: enables
  review:
    summary: Direct assay of recombinant human AdSSL1 demonstrating adenylosuccinate
      synthase activity (adenylosuccinate formation). This is the primary experimental
      evidence for the core molecular function.
    action: ACCEPT
    reason: Strong direct experimental support for the defining catalytic activity of the
      gene product.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
        catalyze adenylosuccinate formation.
- term:
    id: GO:0005525
    label: GTP binding
  evidence_type: NAS
  original_reference_id: PMID:15786719
  qualifier: enables
  review:
    summary: Author statement of GTP binding, reflecting the conserved GTP-dependent
      mechanism of adenylosuccinate synthetase; GTP is a co-substrate of the reaction.
    action: ACCEPT
    reason: Consistent with the well-characterized GTP-dependent catalytic mechanism and
      the multiple GTP-binding regions annotated in UniProt; also independently supported by
      IEA.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:15786719
  qualifier: located_in
  review:
    summary: Direct experimental observation that overexpressed AdSSL1 localizes to the
      cytoplasm in COS-7 cells.
    action: ACCEPT
    reason: Direct localization evidence for the human protein; cytosol (GO:0005829) is the
      more granular equivalent captured from Reactome.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
- term:
    id: GO:0006167
    label: AMP biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:15786719
  qualifier: involved_in
  review:
    summary: Direct evidence linking ADSS1 to AMP biosynthesis via its characterized
      adenylosuccinate-forming activity, the committed step in AMP synthesis.
    action: ACCEPT
    reason: Core biological process, directly supported by the enzyme assay and the
      description of AdSSL1 as catalyzing the first committed step in AMP synthesis.
    supported_by:
    - reference_id: PMID:15786719
      supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
    id: GO:0042301
    label: phosphate ion binding
  evidence_type: NAS
  original_reference_id: PMID:15786719
  qualifier: enables
  review:
    summary: Author statement of phosphate ion binding. Phosphate is a reaction product
      and the enzyme binds the phosphate groups of its GTP/GDP and IMP ligands, but a
      standalone phosphate-ion-binding molecular function is not informative for this
      enzyme.
    action: MARK_AS_OVER_ANNOTATED
    reason: The enzyme's phosphate handling is part of GTP binding and the ligase catalytic
      mechanism (phosphate is released as a product). A discrete phosphate-ion-binding MF
      annotation adds little and risks over-representing an incidental feature; the
      informative functions are GO:0004019 and GO:0005525. Kept (not wrong) but flagged.
    supported_by:
    - reference_id: file:human/ADSS1/ADSS1-uniprot.txt
      supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
        + phosphate
core_functions:
- description: Catalyzes the first committed step of AMP biosynthesis from IMP - the
    Mg2+-dependent, GTP-driven condensation of IMP with L-aspartate to yield
    adenylosuccinate (N6-(1,2-dicarboxyethyl)-AMP), GDP and phosphate (EC 6.3.4.4) - as the
    muscle isozyme of adenylosuccinate synthetase.
  molecular_function:
    id: GO:0004019
    label: adenylosuccinate synthase activity
  directly_involved_in:
  - id: GO:0044208
    label: "'de novo' AMP biosynthetic process"
  - id: GO:0006167
    label: AMP biosynthetic process
  supported_by:
  - reference_id: PMID:15786719
    supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
      catalyze adenylosuccinate formation.
  - reference_id: PMID:26506222
    supporting_text: Both the D304N and I350fs mutations in ADSSL1 led to decreased
      enzymatic activity.
  locations:
  - id: GO:0005829
    label: cytosol
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000104
  title: Electronic Gene Ontology annotations created by transferring manual GO annotations
    between related proteins based on shared sequence features
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:15786719
  title: Molecular cloning and characterization of a novel muscle adenylosuccinate
    synthetase, AdSSL1, from human bone marrow stromal cells.
  findings:
  - statement: Human AdSSL1 is the muscle isozyme of adenylosuccinate synthetase that
      catalyzes the first committed step in AMP synthesis; recombinant protein has typical
      adenylosuccinate synthase activity and the protein localizes to the cytoplasm.
    supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
      catalyze adenylosuccinate formation.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: PubMed-verified; primary characterization of human ADSS1/AdSSL1
      (activity, cytoplasmic localization, muscle-predominant expression). Abstract-only in
      cache but the abstract directly supports the enzymatic and localization annotations.
- id: PMID:26506222
  title: ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy.
  findings:
  - statement: Biallelic ADSSL1 mutations cause autosomal recessive adolescent-onset distal
      myopathy (MPD5); the mutations decrease adenylosuccinate synthase enzymatic activity.
    supporting_text: Both the D304N and I350fs mutations in ADSSL1 led to decreased
      enzymatic activity.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: PubMed-verified; establishes the disease link (MPD5) and provides
      mutant-phenotype (IMP) evidence for the catalytic function. Abstract-only in cache;
      the abstract supports the activity and disease claims.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Proteome-scale interactome study; source of an IntAct IPI protein-binding
      annotation (partner ADSS2). Does not establish a specific molecular function for ADSS1.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Proteome-scale interactome study; source of an IntAct IPI protein-binding
      annotation (partner ADSS2). Uninformative bare protein-binding evidence for ADSS1.
- id: PMID:40205054
  title: Multimodal cell maps as a foundation for structural and functional genomics.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Multimodal cell-map / interactome study; source of an IntAct IPI
      protein-binding annotation (partner ADSS2). Uninformative bare protein-binding evidence.
- id: Reactome:R-HSA-111524
  title: IMP + L-Aspartate + GTP => Adenylosuccinate + GDP + Pi [ADSS]
  findings:
  - statement: Adenylosuccinate synthetase isoforms (including ADSSL1) catalyze the reaction
      of IMP, aspartate, and GTP to form adenylosuccinate, GDP and orthophosphate in the
      cytosol.
    supporting_text: Two isoforms of adenylosuccinate synthetase, ADSS and ADSSL1, catalyze
      the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP, and
      orthophosphate
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Reactome reaction for the adenylosuccinate synthase step; source of the
      cytosol (TAS) localization. Title left exactly as fetched.
- id: file:human/ADSS1/ADSS1-uniprot.txt
  title: UniProt entry Q8N142 (PURA1_HUMAN, ADSS1) - adenylosuccinate synthetase isozyme 1
  findings:
  - statement: ADSS1 catalyzes the Mg2+-dependent, GTP-dependent reaction of IMP with
      L-aspartate to form adenylosuccinate, GDP and phosphate, the first committed step
      (step 1 of 2) of the de novo AMP-from-IMP pathway; it is a cytoplasmic homodimer that
      interacts with the paralog ADSS2.
    supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Curated UniProt record; primary source for reaction, cofactor, pathway,
      subcellular location, and the ADSS1-ADSS2 interaction used in this review.
suggested_questions:
- question: Does ADSS1 have non-catalytic or muscle-specific regulatory roles beyond the
    purine nucleotide cycle that explain the tissue-restricted, distal-predominant myopathy
    phenotype, given the ubiquitously expressed paralog ADSS2?
- question: Is the observed expression of AdSSL1 in stimulated leukemia/hematopoietic cells
    associated with any genuine immune function, or purely a metabolic response?
suggested_experiments:
- description: Steady-state kinetic characterization of purified recombinant human ADSS1
    (Km for IMP, L-aspartate, GTP; Mg2+ dependence) compared with ADSS2, to quantify the
    muscle isozyme's catalytic properties.
  hypothesis: The muscle isozyme ADSS1 has kinetic properties distinct from ADSS2 that suit
    the high purine-nucleotide-cycle flux of skeletal muscle.
- description: Muscle-specific Adss1 knockout or knock-in of the MPD5 D304N variant in mouse
    to test whether purine nucleotide cycle disruption drives the distal myopathy phenotype.
  hypothesis: Loss of ADSS1 catalytic activity impairs the muscle purine nucleotide cycle,
    causing the distal myopathy seen in MPD5 patients.